Michael Canney

Michael Canney, Ph.D., is a prominent scientist and the chief scientific officer of Carthera, a health tech company based in Colorado that focuses on developing innovative medical devices for the treatment of severe brain disorders. He has contributed to the understanding of glioblastoma, one of the most aggressive forms of brain cancer, and has discussed the challenges of treating this disease, including the limitations imposed by the blood-brain barrier. Canney is actively involved in research aimed at finding new treatment options and enhancing patient outcomes, emphasizing the need for clinical trials that offer hope for glioblastoma patients.